GM-CSF Reporter HEK 293 Cells
HEK-Blue™ GM-CSF Cells | Unit size | Cat. code | Docs | Qty | Price |
---|---|---|---|---|---|
Human GM-CSF Reporter Cells |
3-7 x 10e6 cells |
hkb-hgmcsfr |
You may also need : HEK-Blue™ Selection | View more associated products ▼
Notification: This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.
HEK-Blue™ GM-CSF Cells signaling pathway
Granulocyte-Macrophage Colony-Stimulating Factor Reporter Cells
HEK-Blue™ GM-CSF cells were engineered from the human embryonic kidney HEK 293 cell line to detect bioactive granulocyte-macrophage colony-stimulating factor (GM-CSF, aka CSF2) by monitoring the activation of the JAK2/STAT5 pathway. Although originally identified as a hematopoietic growth factor, this cytokine is now regarded as a pleiotropic regulator of inflammation in the responses to pathogens, autoimmune diseases, and cancer [1, 2].
Cell line description:
HEK-Blue™ GM-CSF cells were generated by stable overexpression of the genes encoding for the human GMRα (CD116), GMRβ (CD131), and STAT5, as well as a STAT5-inducible secreted embryonic alkaline phosphatase (SEAP) reporter. STAT5-dependent SEAP activity is readily assessable in the supernatant using QUANTI-Blue™ Solution, a detection reagent.
Features of HEK-Blue™ GM-CSF cells:
- Fully functional GM-CSF signaling pathway
- Readily assessable STAT5-inducible SEAP reporter activity
- The stability for 20 passages has been verified
- Functionally tested and guaranteed mycoplasma-free
Applications of HEK-Blue™ GM-CSF cells:
- Detection of human GM-CSF (5 pg/ml - 100 ng/ml)
- No detection of murine GM-CSF
- Screening of anti-GM-CSF and anti-GMRα antibodies
References:
1. Dougan M. et al., 2019. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 50(4):796-811.
2. Zhan Y. et al., 2019. The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game. Front Immunol. 102679.
3. Hamilton J.A., 2020. GM-CSF in inflammation. J. Exp . Med. 217(1):e20190945.
Specifications
Antibiotic resistance: Blasticidin, hygromycin, and Zeocin®
Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum (FBS; 30 min at 56°C), 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™
Specificity: human GM-CSF
Detection range: 5 pg/ml - 100 ng/ml for human GM-CSF
Quality Control:
- STAT5-dependent SEAP reporter activity in response to human GM-CSF has been validated.
- The cell surface expression of human GMRα (CD116) in this cell line has been validated using fluorescence-activated cell sorting (FACS).
- The stability for 20 passages, following thawing, has been verified.
- These cells are guaranteed mycoplasma-free.
This product is covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 3-7 x 106 HEK-Blue™ GM-CSF cells in a cryovial or shipping flask
- 1 ml Normocin™ (50 mg/ml)
- 2 x 1 ml of HEK-Blue Selection (250X)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent).
Shipped on dry ice (Europe, USA, Canada and some areas in Asia)
Details
The granulocyte-macrophage colony-stimulating factor (GM-CSF, aka CSF2) belongs to the β-common chain cytokine family [1]. Although originally identified as a hematopoietic growth factor, this cytokine is now regarded as a pleiotropic regulator of inflammation in the responses to pathogens, autoimmune diseases, and cancer [1, 2]. GM-CSF signalization requires a multimeric structure comprising four α chains (GMRα, aka CD116), four β chains (GMRβ aka CD131), and four cytokines. This 12-protein complex allows the juxtaposition of the intracellular Janus kinase 2 (JAK2) and activation of the signal transducer and activator of transcription 5 (STAT5) [1]. Other signaling pathways include ERK, NF-κB, and AKT pathways [2, 3].
The understanding of cellular and molecular mechanisms whereby GM-CSF exerts its varied functions is key for the development of therapeutic strategies (e.g. cancer vaccines, blocking antibodies) [1].
1. Dougan M. et al., 2019. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 50(4):796-811.
2. Zhan Y. et al., 2019. The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game. Front Immunol. 102679.
3. Hamilton J.A., 2020. GM-CSF in inflammation. J. Exp . Med. 217(1):e20190945.